What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Padcev and Keytruda combo cuts bladder cancer recurrence risk by 60% in pivotal Phase 3 win Discover how the Padcev and Keytruda combination achieved unprecedented survival gains in bladder cancer — read our expert take. bySrinathOctober 19, 2025